VandenEnden Koert 4
4 · Arbutus Biopharma Corp · Filed Apr 17, 2018
Insider Transaction Report
Form 4
VandenEnden Koert
Chief Accounting Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2018-04-16+25,000→ 25,000 totalExercise: $5.20Exp: 2028-04-16→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The options will vest on termination of employment.